Related references
Note: Only part of the references are listed.Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis
Ziqi Tang et al.
EYE (2021)
Correlations between visual morphological, electrophysiological, and acuity changes in chronic non-arteritic ischemic optic neuropathy
Lucilla Barbano et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy
Sohan Singh Hayreh
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Citicoline and Vitamin B-12 Eye Drops in Type 1 Diabetes: Results of a 3-year Pilot Study Evaluating Morpho-Functional Retinal Changes
Mariacristina Parravano et al.
ADVANCES IN THERAPY (2020)
Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
Stefano Gandolfi et al.
NUTRIENTS (2020)
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
G. R. Tundo et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: Novel insights into its pro-proteostatic effect
Diego Sbardella et al.
BIOCHEMICAL PHARMACOLOGY (2020)
P2X7 receptor antagonism preserves retinal ganglion cells in glaucomatous mice
Giovanni Luca Romano et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial
Luca Rossetti et al.
JOURNAL OF GLAUCOMA (2020)
Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial
Paolo Fogagnolo et al.
BMC OPHTHALMOLOGY (2020)
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes
Fabio Scarinci et al.
SCIENTIFIC REPORTS (2020)
The proteostasis network and its decline in ageing
Mark S. Hipp et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Vitamin B12 in Relation to Oxidative Stress: A Systematic Review
Erik E. van de Lagemaat et al.
NUTRIENTS (2019)
The proteostasis network provides targets for neurodegeneration
Timothy Mark Newton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Attenuating Diabetic Vascular and Neuronal Defects by Targeting P2rx7
Sofia Pavlou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema A Prospective Study
Zihan Sun et al.
OPHTHALMOLOGY (2019)
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas
Claudio Bucolo et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study
Vincenzo Parisi et al.
PLOS ONE (2019)
Cholinergic nervous system and glaucoma: From basic science to clinical applications
Muneeb A. Faiq et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2019)
Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects
Giuseppe Paradies et al.
CELLS (2019)
Role of the P2X7 receptor in the pathogenesis of type 2 diabetes and its microvascular complications
Anna Solini et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up
Michele Lanza et al.
FRONTIERS IN PHARMACOLOGY (2019)
Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution
Carmela Carnevale et al.
PLOS ONE (2019)
In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model
Yuta Kitamura et al.
SCIENTIFIC REPORTS (2019)
Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors
Eugen Brailoiu et al.
CELL REPORTS (2019)
Enhancement of Retinal Function and of Neural Conduction Along the Visual Pathway Induced by Treatment with Citicoline Eye Drops in Liposomal Formulation in Open Angle Glaucoma: A Pilot Electrofunctional Study
Vincenzo Parisi et al.
ADVANCES IN THERAPY (2019)
The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S
Diego Sbardella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Novel Therapeutics in Glaucoma Management
Claudio Bucolo et al.
CURRENT NEUROPHARMACOLOGY (2018)
Neurodegeneration in diabetic retinopathy: does it really matter?
Rafael Simo et al.
DIABETOLOGIA (2018)
Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
Patricia Bogdanov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ischemic optic neuropathy as a model of neurodegenerative disorder: A review of pathogenic mechanism of axonal degeneration and the role of neuroprotection
Saba Khalilpour et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries?
Fabio Scarinci et al.
OPHTHALMOLOGICA (2017)
Cytoprotective Effects of Citicoline and Homotaurine against Glutamate and High Glucose Neurotoxicity in Primary Cultured Retinal Cells
Sergio Davinelli et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis
Seth R. Flaxman et al.
LANCET GLOBAL HEALTH (2017)
Regulating protein breakdown through proteasome phosphorylation
Jordan J. S. VerPlank et al.
BIOCHEMICAL JOURNAL (2017)
Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
Grazia R. Tundo et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
P2X7 receptor antagonism: Implications in diabetic retinopathy
Chiara Bianca Maria Platania et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
Fabiana Picconi et al.
ACTA DIABETOLOGICA (2017)
The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death
Ido Livneh et al.
CELL RESEARCH (2016)
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990-2010 (vol 39, pg 1643, 2016)
Janet L. Leasher et al.
DIABETES CARE (2016)
Retinal Ganglion Cell Loss Precedes Retinal Nerve Fiber Thinning in Nonarteritic Anterior Ischemic Optic Neuropathy
Mohammadreza Akbari et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2016)
Retinal Ganglion Cell Layer Thinning Within One Month of Presentation for Non-Arteritic Anterior Ischemic Optic Neuropathy
Mark J. Kupersmith et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Electrophysiological assessment of retinal ganglion cell function
Vittorio Porciatti
EXPERIMENTAL EYE RESEARCH (2015)
Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma
Vincenzo Parisi et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2015)
Cytidine 5′-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Gloria Roberti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
Arup Das et al.
OPHTHALMOLOGY (2015)
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution
Diego Sbardella et al.
PLOS ONE (2015)
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives
Pietro Gareri et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Neuroprotective Properties of Citicoline: Facts, Doubts and Unresolved Issues
Pawel Grieb
CNS DRUGS (2014)
Neuroprotection by rat Muller glia against high glucose-induced neurodegeneration through a mechanism involving ERK1/2 activation
Andrea Matteucci et al.
EXPERIMENTAL EYE RESEARCH (2014)
A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy
Gloria Roberti et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2014)
Neuroprotective Effects of Citicoline in in Vitro Models of Retinal Neurodegeneration
Andrea Matteucci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Phosphatidylcholine and the CDP-choline cycle
Paolo Fagone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke
Olivia Hurtado et al.
JOURNAL OF NEUROCHEMISTRY (2013)
The Ubiquitin-Proteasome System in Retinal Health and Disease
Laura Campello et al.
MOLECULAR NEUROBIOLOGY (2013)
Citicoline Oral Solution in Glaucoma: Is There a Role in Slowing Disease Progression?
L. Ottobelli et al.
OPHTHALMOLOGICA (2013)
Autophagy in Retinal Ganglion Cells in a Rhesus Monkey Chronic Hypertensive Glaucoma Model
Shuifeng Deng et al.
PLOS ONE (2013)
Retinal Layers Changes in Human Preclinical and Early Clinical Diabetic Retinopathy Support Early Retinal Neuronal and Muller Cells Alterations
Stela Vujosevic et al.
JOURNAL OF DIABETES RESEARCH (2013)
Retinal Function and Neural Conduction Along the Visual Pathways in Affected and Unaffected Carriers With Leber's Hereditary Optic Neuropathy
Lucia Ziccardi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications
Rafael Simo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement
Elma E. Chang et al.
OPHTHALMOLOGY (2012)
Patterns of Ganglion Cell Complex and Nerve Fiber Layer Loss in Nonarteritic Ischemic Optic Neuropathy by Fourier-Domain Optical Coherence Tomography
Divya Aggarwal et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose
Toshiyuki Oshitari et al.
BRAIN RESEARCH (2010)
Autophagy: cellular and molecular mechanisms
Danielle Glick et al.
JOURNAL OF PATHOLOGY (2010)
Electrophysiological Detection of Delayed Postretinal Neural Conduction in Human Amblyopia
Vincenzo Parisi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community A cross-sectional study
Neil T. Raymond et al.
DIABETES CARE (2009)
Single- and Repeated-Dose Oral Toxicity Studies of Citicoline Free-Base (Choline Cytidine 5′-Pyrophosphate) in Sprague-Dawley Rats
A. G. Schauss et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2009)
Ischemic optic neuropathy
Sohan Singh Hayreh
PROGRESS IN RETINAL AND EYE RESEARCH (2009)
Retinal arteriolar caliber predicts incident retinopathy
Sophie Louise Rogers et al.
DIABETES CARE (2008)
Cytidine-5'-diphosphocholine (Citicoline): a pilot study in patients with non-arteritic ischaemic optic neuropathy
V. Parisi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Retinal nerve fiber layer thickness in nonarteritic anterior ischemic optic neuropathy: OCT characterization of the acute and resolving phases
Costantino Bellusci et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006
Xi Wei Xie et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke
O. Hurtado et al.
NEUROBIOLOGY OF DISEASE (2008)
Prevalence and Risk Factors for Diabetic Retinopathy The Singapore Malay Eye Study
Tien Y. Wong et al.
OPHTHALMOLOGY (2008)
Nonarteritic anterior ischemic optic neuropathy - Natural history of visual outcome
Sohan Singh Hayreh et al.
OPHTHALMOLOGY (2008)
Targeting amyloid-β in glaucoma treatment
Li Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Surrogate markers of small fiber damage in human diabetic neuropathy
Cristian Quattrini et al.
DIABETES (2007)
Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy
Erica L. Fletcher et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat
Frank Schuettauf et al.
EXPERIMENTAL EYE RESEARCH (2006)
Electrophysiological findings in patients with nonarteritic anterior ischemic optic neuropathy
M Janáky et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Sigma receptor ligands protect human retinal cells against oxidative stress
C Bucolo et al.
NEUROREPORT (2006)
Diabetic retinopathy - Seeing beyond glucose-induced microvascular disease
David A. Antonetti et al.
DIABETES (2006)
Pattern electroretinography and visual evoked potentials in optic nerve diseases
H Atilla et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2006)
Neuroprotective effect of citicoline against KA-induced neurotoxicity in the rat retina
CH Park et al.
EXPERIMENTAL EYE RESEARCH (2005)
Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia
J Krupinski et al.
NEUROCHEMICAL RESEARCH (2005)
Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5 '-diphosphocholine (citicoline): a study of 8 years of follow-up
V Parisi
DOCUMENTA OPHTHALMOLOGICA (2005)
Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction - A pilot study
LM Ventura et al.
OPHTHALMOLOGY (2005)
The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States
MS Roy et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg
A Ciechanover et al.
NEURON (2003)
Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia
RM Adibhatla et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Relationship between β-amyloid degradation and the 26S proteasome in neural cells
ML Salon et al.
EXPERIMENTAL NEUROLOGY (2003)
CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons
C Mir et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina
T Oshitari et al.
NEUROREPORT (2002)
Citicoline treatment increases retinal dopamine content in rabbits
R Rejdak et al.
OPHTHALMIC RESEARCH (2002)
CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat
J Krupinski et al.
NEUROPHARMACOLOGY (2002)
Pharmacodynamics of citicoline relevant to the treatment of glaucoma
P Grieb et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Impaired visual function in glaucoma
V Parisi
CLINICAL NEUROPHYSIOLOGY (2001)
The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up)
M Virno et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2000)
Share Paper
